A team of scientists has found that suppressing a newly discovered gene lengthens the lifespan of roundworms. The results offer promising early evidence that scientists may succeed at finding targets for drugs that someday could allow people to live longer, healthier lives.
Researchers have determined that the use of drug-eluting stents improves the long-term clinical outcome for patients undergoing percutaneous coronary intervention, commonly known as angioplasty.
Clavis Pharma, the Norwegian cancer drug development company, announces that it has recruited the first patient into its pivotal Phase 3 study assessing its lead product elacytarabine in patients with late-stage acute myeloid leukemia.
ImmunoGen, Inc., a developer of antibody-based targeted anticancer products, announced that the FDA has granted orphan drug designation to lorvotuzumab mertansine when used for the treatment of small-cell lung cancer (SCLC).
Tai chi eased painful joints and other symptoms of fibromyalgia in a small but well-done study of this ancient Chinese form of exercise.
Bristol-Myers Squibb Company announced that the FDA has accepted, for filing and review, the Biologics License Application for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated.
Johnson & Johnson is creating a new position to oversee companywide quality, manufacturing and compliance issues and appointing chief quality officers for each of its three major business units.
StemCells, Inc., announced the publication of new preclinical data demonstrating that the company’s proprietary human neural stem cells restore lost motor function in mice with chronic spinal cord injury.
Shares of Endo Pharmaceuticals Holdings Inc. jumped this week after an analyst said Endo can keep generic versions of its painkiller Opana ER from being approved, which would sustain sales until Endo starts selling a new version.
One of the prerequisites for the success of a clinical trial is to ensure that the effective drugs and placebos involved cannot be distinguished from each other. Schreiner MediPharm has now developed a solution which neutralizes the appearance of liquids in transparent containers.
Bio-Rad Laboratories introduces the SsoFast EvaGreen control assay, a prepackaged kit that helps labs conveniently verify their real-time PCR instrument performance.
Genetix announces that it was granted a patent, US 7,776,584. Aspects of this patent are incorporated into ClonePix FL, which is used for the screening and selection of cell lines producing biopharmaceuticals.
Phylogica Ltd, a public Australian drug discovery company, announced that they have entered into an agreement with MedImmune to evaluate Phylogica’s proprietary Phylomer peptide library for novel antimicrobial peptides.
Shares of Jazz Pharmaceuticals Inc. jumped after federal health officials said one of its drugs appears effective for treating a chronic pain disorder.